NF2 and meningioma: The most striking differences of time to recurrence was seen between subclusters A1 and A2 within cluster A. While both A1 and A2 harbored meningiomas with biallelic inactivation of NF2 and loss of chr1p, subcluster A2 contained a much larger population of patients with poor outcomes compared to subcluster A1 (28).